MicroRNA-218 instructs proper assembly of hippocampal networks

  1. Seth R Taylor  Is a corresponding author
  2. Mariko Kobayashi
  3. Antonietta Vilella
  4. Durgesh Tiwari
  5. Norjin Zolboot
  6. Jessica X Du
  7. Kathryn R Spencer
  8. Andrea Hartzell
  9. Carol Girgiss
  10. Yusuf T Abaci
  11. Yufeng Shao
  12. Claudia De Sanctis
  13. Gian Carlo Bellenchi
  14. Robert B Darnell
  15. Christina Gross
  16. Michele Zoli
  17. Darwin K Berg
  18. Giordano Lippi  Is a corresponding author
  1. Brigham Young University, United States
  2. Howard Hughes Medical Institute, Rockefeller University, United States
  3. University of Modena and Reggio Emilia, Italy
  4. Cincinnati Children's Hospital Medical Center, United States
  5. Scripps Research Institute, United States
  6. University of California, San Diego, United States
  7. Institute of Genetics and Biophysics A Buzzati-Traverso, Italy

Abstract

The assembly of the mammalian brain is orchestrated by temporally coordinated waves of gene expression. Post-transcriptional regulation by microRNAs (miRNAs) is a key aspect of this program. Indeed, deletion of neuron-enriched miRNAs induces strong developmental phenotypes, and miRNA levels are altered in patients with neurodevelopmental disorders. However, the mechanisms used by miRNAs to instruct brain development remain largely unexplored. Here, we identified miR-218 as a critical regulator of hippocampal assembly. MiR-218 is highly expressed in the hippocampus and enriched in both excitatory principal neurons (PNs) and GABAergic inhibitory interneurons (INs). Early life inhibition of miR-218 results in an adult brain with a predisposition to seizures. Changes in gene expression in the absence of miR-218 suggest that network assembly is impaired. Indeed, we find that miR-218 inhibition results in the disruption of early depolarizing GABAergic signaling, structural defects in dendritic spines, and altered intrinsic membrane excitability. Conditional knockout of Mir218-2 in INs, but not PNs, is sufficient to recapitulate long-term instability. Finally, de-repressing Kif21b and Syt13, two miR-218 targets, phenocopies the effects on early synchronous network activity induced by miR-218 inhibition. Taken together, the data suggest that miR-218 orchestrates formative events in PNs and INs to produce stable networks.

Data availability

RNA-seq data has been deposited to GEO (accession number GSE241245)

The following data sets were generated

Article and author information

Author details

  1. Seth R Taylor

    Division of Biological Sciences, Brigham Young University, Provo, United States
    For correspondence
    seth_taylor@byu.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Mariko Kobayashi

    Laboratory of Molecular Neuro-oncology, Howard Hughes Medical Institute, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Antonietta Vilella

    Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Durgesh Tiwari

    Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Norjin Zolboot

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jessica X Du

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Kathryn R Spencer

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Andrea Hartzell

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Carol Girgiss

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Yusuf T Abaci

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Yufeng Shao

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Claudia De Sanctis

    Institute of Genetics and Biophysics A Buzzati-Traverso, Naples, Italy
    Competing interests
    The authors declare that no competing interests exist.
  13. Gian Carlo Bellenchi

    Institute of Genetics and Biophysics A Buzzati-Traverso, Naples, Italy
    Competing interests
    The authors declare that no competing interests exist.
  14. Robert B Darnell

    Laboratory of Molecular Neuro-oncology, Howard Hughes Medical Institute, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5134-8088
  15. Christina Gross

    Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6057-2527
  16. Michele Zoli

    Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    The authors declare that no competing interests exist.
  17. Darwin K Berg

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Giordano Lippi

    Department of Neuroscience, Scripps Research Institute, La Jolla, United States
    For correspondence
    glippi@scripps.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3911-0525

Funding

National Institutes of Health (1 S10 OD026817-01)

  • Giordano Lippi

Ministero dell'Istruzione, dell'Università e della Ricerca (1R01NS092705)

  • Michele Zoli

National Institutes of Health (2R01NS012601)

  • Darwin K Berg

National Institutes of Health (1R21NS087342)

  • Darwin K Berg

National Institutes of Health (1R01NS121223)

  • Giordano Lippi

National Institutes of Health (1R01NS092705)

  • Christina Gross

Tobacco-Related Disease Research Program (22XT-0016,21FT-0027)

  • Darwin K Berg

Whitehall Foundation (2018-12-55)

  • Giordano Lippi

Autism Speaks (12923)

  • Norjin Zolboot

American Epilepsy Society (12923)

  • Andrea Hartzell

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. John R Huguenard, Stanford University School of Medicine, United States

Ethics

Animal experimentation: All experimental procedures at UCSD, CCHMH and SRI were performed as approved by the Institutional Animal Care and Use Committees and according to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Behavioral and in vivo experiments at UNIMORE were conducted in accordance with the European Community Council Directive (86/609/EEC) of November 24, 1986, and approved by the ethics committee (authorization number: 37/2018PR).

Version history

  1. Received: August 16, 2022
  2. Preprint posted: August 25, 2022 (view preprint)
  3. Accepted: October 10, 2023
  4. Accepted Manuscript published: October 20, 2023 (version 1)
  5. Version of Record published: November 10, 2023 (version 2)

Copyright

© 2023, Taylor et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 901
    views
  • 142
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Seth R Taylor
  2. Mariko Kobayashi
  3. Antonietta Vilella
  4. Durgesh Tiwari
  5. Norjin Zolboot
  6. Jessica X Du
  7. Kathryn R Spencer
  8. Andrea Hartzell
  9. Carol Girgiss
  10. Yusuf T Abaci
  11. Yufeng Shao
  12. Claudia De Sanctis
  13. Gian Carlo Bellenchi
  14. Robert B Darnell
  15. Christina Gross
  16. Michele Zoli
  17. Darwin K Berg
  18. Giordano Lippi
(2023)
MicroRNA-218 instructs proper assembly of hippocampal networks
eLife 12:e82729.
https://doi.org/10.7554/eLife.82729

Share this article

https://doi.org/10.7554/eLife.82729

Further reading

    1. Neuroscience
    Salima Messaoudi, Ada Allam ... Isabelle Caille
    Research Article

    The fragile X syndrome (FXS) represents the most prevalent form of inherited intellectual disability and is the first monogenic cause of autism spectrum disorder. FXS results from the absence of the RNA-binding protein FMRP (fragile X messenger ribonucleoprotein). Neuronal migration is an essential step of brain development allowing displacement of neurons from their germinal niches to their final integration site. The precise role of FMRP in neuronal migration remains largely unexplored. Using live imaging of postnatal rostral migratory stream (RMS) neurons in Fmr1-null mice, we observed that the absence of FMRP leads to delayed neuronal migration and altered trajectory, associated with defects of centrosomal movement. RNA-interference-induced knockdown of Fmr1 shows that these migratory defects are cell-autonomous. Notably, the primary Fmrp mRNA target implicated in these migratory defects is microtubule-associated protein 1B (MAP1B). Knocking down MAP1B expression effectively rescued most of the observed migratory defects. Finally, we elucidate the molecular mechanisms at play by demonstrating that the absence of FMRP induces defects in the cage of microtubules surrounding the nucleus of migrating neurons, which is rescued by MAP1B knockdown. Our findings reveal a novel neurodevelopmental role for FMRP in collaboration with MAP1B, jointly orchestrating neuronal migration by influencing the microtubular cytoskeleton.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Maximilian Nagel, Marco Niestroj ... Marc Spehr
    Research Article

    In most mammals, conspecific chemosensory communication relies on semiochemical release within complex bodily secretions and subsequent stimulus detection by the vomeronasal organ (VNO). Urine, a rich source of ethologically relevant chemosignals, conveys detailed information about sex, social hierarchy, health, and reproductive state, which becomes accessible to a conspecific via vomeronasal sampling. So far, however, numerous aspects of social chemosignaling along the vomeronasal pathway remain unclear. Moreover, since virtually all research on vomeronasal physiology is based on secretions derived from inbred laboratory mice, it remains uncertain whether such stimuli provide a true representation of potentially more relevant cues found in the wild. Here, we combine a robust low-noise VNO activity assay with comparative molecular profiling of sex- and strain-specific mouse urine samples from two inbred laboratory strains as well as from wild mice. With comprehensive molecular portraits of these secretions, VNO activity analysis now enables us to (i) assess whether and, if so, how much sex/strain-selective ‘raw’ chemical information in urine is accessible via vomeronasal sampling; (ii) identify which chemicals exhibit sufficient discriminatory power to signal an animal’s sex, strain, or both; (iii) determine the extent to which wild mouse secretions are unique; and (iv) analyze whether vomeronasal response profiles differ between strains. We report both sex- and, in particular, strain-selective VNO representations of chemical information. Within the urinary ‘secretome’, both volatile compounds and proteins exhibit sufficient discriminative power to provide sex- and strain-specific molecular fingerprints. While total protein amount is substantially enriched in male urine, females secrete a larger variety at overall comparatively low concentrations. Surprisingly, the molecular spectrum of wild mouse urine does not dramatically exceed that of inbred strains. Finally, vomeronasal response profiles differ between C57BL/6 and BALB/c animals, with particularly disparate representations of female semiochemicals.